Molecular profiles and response among metastatic renal cell carcinoma patients treated with targeted therapies

被引：0
|
作者：
Donskov, F. [1 ]
Pinto, C. A. [2 ]
Predoui, R. [2 ]
Kong, F. [2 ]
Fox, C. [2 ]
Georgsen, J. [1 ]
Skaarup, K. [3 ]
Perini, R. [2 ]
Steiniche, T. [1 ]
机构：
[1] Aarhus Univ Hosp, Pathol, Aarhus, Denmark
[2] Merck & Co Inc, Clin Res, Kenilworth, NJ USA
[3] MSD Danmark, Oncol, Copenhagen, Denmark
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
155P
引用
收藏
页码：S301 / S301
页数：1
相关论文
共 50 条
  • [31] Clinical impact of targeted therapies in patients with metastatic clear-cell renal cell carcinoma
    Nerich, Virginie
    Hugues, Marion
    Paillard, Marie Justine
    Borowski, Laetitia
    Nai, Thierry
    Stein, Ulrich
    Hon, Thierry Nguyen Tan
    Montcuquet, Philippe
    Maurina, Tristan
    Mouillet, Guillaume
    Kleinclauss, Francois
    Pivot, Xavier
    Limat, Samuel
    Thiery-Vuillemin, Antoine
    [J]. ONCOTARGETS AND THERAPY, 2014, 7 : 365 - 374
  • [32] Outcome of metastatic renal cell carcinoma (mRCC) patients in the era of new targeted therapies
    Ruiz, A. L.
    Bolos, M. V.
    Viqueira, A.
    Esteban, E.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S654 - S654
  • [33] COMPARISON OF TWO MAJOR PROGNOSTIC MODELS FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED IN THE CONTEMPORARY ERA OF TARGETED THERAPIES
    Crepel, Maxime
    Bernhard, Jean-Christophe
    Joly, Florence
    Ravaud, Alain
    Guy, Laurent
    Glavis, Gwenaelle
    Chevreau, Christine
    Zini, Laurent
    Lang, Herve
    Staehler, Michael
    Pfister, Alain
    Salomon, Laurent
    Bastien, Laurence
    Lechevallier, Eric
    Fais, Pierre-Olivier
    Azzouzi, Rahmene
    Bigot, Pierre
    Roupret, Morgan
    Rigaud, Jerome
    Vayleux, Bertrand
    Descazeaud, Aurelien
    Berger, Julien
    Kleinclauss, Francois
    Machiels, Jean-Pascal
    Patard, Jean-Jacques
    [J]. JOURNAL OF UROLOGY, 2011, 185 (04): : E712 - E713
  • [34] Characterizing the Impact of Lymph Node Metastases on the Survival Outcome for Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapies
    Kroeger, Nils
    Pantuck, Allan J.
    Wells, J. Connor
    Lawrence, Nicola
    Broom, Reuben
    Kim, Jenny J.
    Srinivas, Sandy
    Yim, Jessica
    Bjarnason, Georg A.
    Templeton, Arnoud
    Knox, Jennifer
    Bernstein, Ezra
    Smoragiewicz, Martin
    Lee, Jae
    Rini, Brian I.
    Vaishampayan, Ulka N.
    Woodm, Lori A.
    Beuselinck, Benoit
    Donskov, Frede
    Choueiri, Toni K.
    Heng, Daniel Y.
    [J]. EUROPEAN UROLOGY, 2015, 68 (03) : 506 - 515
  • [35] Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma
    Nouhaud, Francois-Xavier
    Pfister, Christian
    Defortescu, Guillaume
    Giwerc, Anthony
    Charbit, David
    Gouerant, Sophie
    Sabourin, Jean-Christophe
    Di Fiore, Frederic
    [J]. ANTI-CANCER DRUGS, 2015, 26 (08) : 866 - 871
  • [36] The Prognostic Value of Systemic Inflammatory Markers in Advanced Renal Cell Carcinoma Patients Treated With Molecular Targeted Therapies
    Ueda, Kosuke
    Ogasawara, Naoyuki
    Yonekura, Satoru
    Matsunaga, Yoshihiro
    Hoshino, Ryuji
    Kurose, Hirofumi
    Chikui, Katsuaki
    Uemura, Keiichiro
    Nakiri, Makoto
    Nishihara, Kiyoaki
    Matsuo, Mitsunori
    Suekane, Shigetaka
    Igawa, Tsukasa
    [J]. ANTICANCER RESEARCH, 2020, 40 (03) : 1739 - 1745
  • [37] Targeted and immune therapies among patients with metastatic renal carcinoma undergoing hemodialysis: A systemic review
    Klajer, Elodie
    Garnier, Louis
    Goujon, Morgan
    Schlurmann-Constans, Friederike
    Mery, Benoite
    Hon, Thierry Nguyen Tan
    Mouillet, Guillaume
    Calcagno, Fabien
    Thiery-Vuillemin, Antoine
    [J]. SEMINARS IN ONCOLOGY, 2020, 47 (2-3) : 103 - 116
  • [38] Selecting Targeted Therapies for Patients With Renal Cell Carcinoma
    Plimack, Elizabeth R.
    Hudes, Gary R.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (09): : 997 - 1007
  • [39] Major Adverse Cardiovascular Events in Patients With Renal Cell Carcinoma Treated With Targeted Therapies
    Chen, Dong-Yi
    Liu, Jia-Rou
    Tseng, Chi-Nan
    Hsieh, Ming-Jer
    Chuang, Cheng-Keng
    Pang, See-Tong
    Chen, Shao-Wei
    Hsieh, I-Chang
    Chu, Pao-Hsien
    Chen, Jen-Shi
    Chang, John Wen-Cheng
    Huang, Wen-Kuan
    See, Lai-Chu
    [J]. JACC: CARDIOONCOLOGY, 2022, 4 (02): : 223 - 234
  • [40] Surgical management of metastatic renal cell carcinoma in the era of targeted therapies
    Laura-Maria Krabbe
    Ahmed Q. Haddad
    Mary E. Westerman
    Vitaly Margulis
    [J]. World Journal of Urology, 2014, 32 : 615 - 622
12345